Search Results for: ES cell

Utah stem cell law OKs non-FDA approved placental cell drug therapies likely sparking conflict

Utah Rep. Katy Hall

Utah appears ready to pass a new stem cell law that would explicitly allow clinical use of non-FDA-approved placental cell drug therapies in the state. Bill 199 seems likely to set up a conflict with the FDA that may land in court. The key part of the bill says: “A health care provider whose scope …

Utah stem cell law OKs non-FDA approved placental cell drug therapies likely sparking conflict Read More »

Long-term hope on stem cells for deafness

stem cells for deafness

A reader of The Niche recently asked me, “What about stem cells for deafness?” It’s a great question and, as they pointed out, stem cells for vision loss gets much more attention. I’ve covered the translational progress of stem cells to treat many diseases but there has been less progress for deafness in the regenerative …

Long-term hope on stem cells for deafness Read More »

Perspectives 10 years after STAP cells: the culture of science, misconduct, & hopes for progress

Haruko-Obokata-小保方-晴子-

Exactly ten years ago today, on January 29, 2014, I wrote about two new Nature papers on so-called STAP cells. The papers claimed that stress alone could convert regular non-stem cells into some of the most powerful stem cells. More specifically, the authors claimed to make pluripotent stem cells similar to iPS cells this way. …

Perspectives 10 years after STAP cells: the culture of science, misconduct, & hopes for progress Read More »

Weekly stem cell reads: cancer paper mess at DFCI, H3.3, knees, surfer keeps on posting

Sholto David, stem cell, cancer retractions

It’s another one of those ‘double-grant’ weekends of grant writing (on brain cancer) and reviewing, but I’m still trying to find a bit of time for some other reading. There was some important news this week including a big mess of problematic papers at Dana Farber Cancer Institute (DFCI). Recommended reads Here’s the new WaPo …

Weekly stem cell reads: cancer paper mess at DFCI, H3.3, knees, surfer keeps on posting Read More »

Put on a happy face? Perspectives on Mayo Clinic stem cells for heart disease Ph3 pub

stem cells for heart disease

One of the first regenerative medicine talks I ever saw was on stem cells for heart disease. I was still a trainee at the time. The professor, whom I won’t name, presented data from an early phase trial reporting that direct injections of some kind of cells right into the heart improved outcomes. Stem cells …

Put on a happy face? Perspectives on Mayo Clinic stem cells for heart disease Ph3 pub Read More »

2023 stem cell predictions grades reflect wild year for regenerative medicine

stem cell predictions

Every year I make stem cell and regenerative medicine predictions. Looking at my predictions for 2023, they reflect a wild year but in many ways a good one overall. Below I have graded my 2023 predictions. Overall, my crystal ball gave solid results. Some of the predictions have been condensed to keep things concise, but you …

2023 stem cell predictions grades reflect wild year for regenerative medicine Read More »

Holiday reads: woolly dog vs. mammoth, man eggs, designer B-cells, bluebird bio blues

woolly dog

What is a woolly dog? Is it somehow related to the Woolly Mammoth? Before we get into that and the rest of my recommended reads, note that I’m finalizing my list of contenders for this year’s The Screamers Science Hype Awards. Last year The BBC won The Screamers for an article “Baby’s life ‘probably saved’ …

Holiday reads: woolly dog vs. mammoth, man eggs, designer B-cells, bluebird bio blues Read More »

Weekly reads: RMAT jump, tissues as liquid crystals, gov stem cell advisor scammed of $650K

RMAT, FDA data

The FDA has a unique mechanism called RMAT or regenerative medicine advanced therapy designation. It’s intended to move investigational regenerative therapies forward more effectively. RMAT data I recently updated The Niche RMAT list and it has jumped to 85. The FDA has approved many new RMATs this year. The data on how many applications the FDA …

Weekly reads: RMAT jump, tissues as liquid crystals, gov stem cell advisor scammed of $650K Read More »

Another kind of stem cell tragedy: William P. Murphy passes at 100

William P. Murphy, US Stem Cell

It’s kind of a tragedy that William P. Murphy, former chairman of unproven stem cell clinic firm, US Stem Cell, might be most remembered after his recent passing for his doings there.  For example, I didn’t know until now of his prolific past as a biomedical inventor who did a lot of good. Instead, my impression of …

Another kind of stem cell tragedy: William P. Murphy passes at 100 Read More »

Weekly reads: FDA OKs 2 gene therapies for sickle cell, new Paolo Macchiarini series, Fujifilm

Marie Tornyenu, Casgevy gene therapies for sickle cell

The big news broke Friday that the FDA approved two new gene therapies for sickle cell disease. While the approvals were expected and the actual use of these treatments will be complex on several levels, this is a historic development. 2 FDA-approved gene therapies for sickle cell Friday’s news follows on recent UK approval for …

Weekly reads: FDA OKs 2 gene therapies for sickle cell, new Paolo Macchiarini series, Fujifilm Read More »